Skip to Content

Feverfew use while Breastfeeding

Feverfew Levels and Effects while Breastfeeding

Summary of Use during Lactation

Feverfew (Tanacetum parthenium) leaves contain sesquiterpene lactones, including parthenolide, which is thought to be the principal active ingredient. Feverfew has no specific lactation-related uses. It is most commonly used to prevent migraine. No data exist on the excretion of any components of feverfew into breastmilk or on the safety and efficacy of feverfew in nursing mothers or infants. Feverfew is generally well tolerated in adults, with occasional oral ulcers or gastrointestinal irritation. Rebound headaches can occur with rapid discontinuation and allergic reactions, including cross-reactions to chrysanthemums, daisies and marigolds, occur rarely. Because of the lack of safety data during lactation, some reviewers recommend against its use during breastfeeding.[1]

Dietary supplements do not require extensive pre-marketing approval from the US Food and Drug Administration. Manufacturers are responsible to ensure the safety, but do not need to prove the safety and effectiveness of dietary supplements before they are marketed. Dietary supplements may contain multiple ingredients, and differences are often found between labeled and actual ingredients or their amounts. A manufacturer may contract with an independent organization to verify the quality of a product or its ingredients, but that does not certify the safety or effectiveness of a product. Because of the above issues, clinical testing results on one product may not be applicable to other products. More detailed information about dietary supplements is available elsewhere on the LactMed Web site.

Drug Levels

Maternal Levels. Relevant published information was not found as of the revision date.

Infant Levels. Relevant published information was not found as of the revision date.

Effects in Breastfed Infants

Relevant published information was not found as of the revision date.

Effects on Lactation and Breastmilk

Relevant published information was not found as of the revision date.

References

1. Amir LH, Pirotta MV, Raval M. Breastfeeding - Evidence based guidelines for the use of medicines. Aust Fam Physician. 2011;40:684-90. PMID: 21894275

Feverfew Identification

Substance Name

Feverfew

Scientific Name

Tanacetum parthenium

CAS Registry Number

89997-65-9

Drug Class

Complementary Therapies

Phytotherapy

Plants, Medicinal

Administrative Information

LactMed Record Number

944

Last Revision Date

20150310

Disclaimer

Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.

Disclaimer: This information is not intended as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. Use of this website signifies your agreement to the Terms of Use and Online Privacy Policy.

Hide